Teacher Retirement System of Texas Cuts Stake in Pediatrix Medical Group, Inc. $MD

Teacher Retirement System of Texas lessened its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 58.6% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 153,856 shares of the company’s stock after selling 217,900 shares during the period. Teacher Retirement System of Texas owned 0.18% of Pediatrix Medical Group worth $2,208,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Boston Partners grew its stake in Pediatrix Medical Group by 1.3% in the first quarter. Boston Partners now owns 1,981,889 shares of the company’s stock valued at $27,990,000 after purchasing an additional 25,536 shares during the last quarter. Invesco Ltd. grew its stake in Pediatrix Medical Group by 9.3% in the first quarter. Invesco Ltd. now owns 863,269 shares of the company’s stock valued at $12,509,000 after purchasing an additional 73,157 shares during the last quarter. Principal Financial Group Inc. grew its stake in Pediatrix Medical Group by 6.2% in the first quarter. Principal Financial Group Inc. now owns 586,190 shares of the company’s stock valued at $8,494,000 after purchasing an additional 34,266 shares during the last quarter. Bridgeway Capital Management LLC grew its stake in Pediatrix Medical Group by 1.7% in the first quarter. Bridgeway Capital Management LLC now owns 554,452 shares of the company’s stock valued at $8,034,000 after purchasing an additional 9,007 shares during the last quarter. Finally, Nuveen LLC purchased a new position in Pediatrix Medical Group in the first quarter valued at about $8,024,000. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Wall Street Analysts Forecast Growth

MD has been the topic of several analyst reports. Zacks Research lowered Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 7th. Leerink Partners boosted their target price on Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a “market perform” rating in a research note on Friday, September 5th. Wall Street Zen upgraded Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 4th. UBS Group boosted their price target on Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a “neutral” rating in a research note on Thursday, August 14th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Pediatrix Medical Group in a research note on Wednesday, October 8th. Two investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $17.25.

Pediatrix Medical Group Price Performance

Shares of NYSE MD opened at $21.14 on Tuesday. The business’s 50 day moving average price is $16.92 and its 200 day moving average price is $14.89. The firm has a market cap of $1.84 billion, a P/E ratio of 16.39 and a beta of 1.26. Pediatrix Medical Group, Inc. has a 52 week low of $11.84 and a 52 week high of $21.24. The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.70.

Pediatrix Medical Group (NYSE:MD) last issued its earnings results on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, beating analysts’ consensus estimates of $0.42 by $0.11. The firm had revenue of $468.84 million for the quarter, compared to analyst estimates of $464.37 million. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.Pediatrix Medical Group’s revenue for the quarter was down 7.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.34 earnings per share. On average, sell-side analysts expect that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.